Browse the evidence

The D2O stable isotopic tracer methodology allows for the assessment of muscle protein synthesis (MPS) over extended periods (days to weeks) in free-living settings, overcoming the limitations of short-term infusion methods.

Current research methods are evolving to better understand how muscle protein synthesis works over days and weeks, not just hours. This helps us see how consistent training and nutrition actually build muscle over time, rather than just looking at immediate spikes.

Dramatic weight loss triggers a disproportionate, long-lasting reduction in resting metabolic rate (metabolic adaptation) that actively counteracts weight maintenance, making long-term maintenance of extreme weight loss biologically difficult without sustained environmental support.

If you have lost a significant amount of weight, expect your metabolism to slow down more than predicted by your new size. This is biology, not failure. To maintain your weight, you must sustain the lifestyle changes (diet and activity) that got you there, rather than returning to old habits. Monitor your weight frequently and be prepared to re-engage with your healthy behaviors if you see small gains.

Higher rates of in vivo adipose triglyceride (TG) synthesis and de novo lipogenesis (DNL) are negatively correlated with body weight loss in women with obesity.

You might think that if your body is good at making new fat (de novo lipogenesis), it would be harder to lose weight. However, this study found the opposite: women who lost more weight actually had higher rates of fat synthesis and turnover in their fat tissue. This suggests that a dynamic, active fat metabolism might be helpful for weight loss, rather than a slow, stagnant one. It highlights that fat turnover is complex and not just about 'making fat'.

Despite significant losses in absolute muscle strength and lean mass, relative muscle strength (strength per unit of body weight or lean mass) and physical function (sit-to-stand time, 6-minute walk distance) improve significantly within one year of metabolic/bariatric surgery, regardless of the specific surgical procedure.

You will lose some muscle mass and absolute strength after surgery, which is normal. However, because you are losing a lot of body weight, your relative strength (strength for your body size) and physical function (walking, standing up) will likely improve. Focus on maintaining muscle through protein intake and light activity rather than fearing the inevitable loss.

Very low calorie diets (VLCD) produce superior short-term weight loss (approx. 4 kg more than behavioral programs) and modest long-term benefits (1.3-1.4 kg) compared to standard behavioral weight loss programs, though long-term maintenance requires adjunctive support.

If you need significant weight loss, a Very Low Calorie Diet (VLCD) under medical supervision produces more weight loss than standard diet advice alone, both immediately and up to 5 years later. However, because regain is common, you should plan for long-term support (like meal replacements or medication) to keep the weight off.

Bariatric surgery's glycemic benefits in patients with BMI <35 kg/m2 are primarily driven by caloric restriction and weight loss rather than unique metabolic or hormonal mechanisms.

For patients with BMI <35, surgery is not a 'metabolic cure' distinct from weight loss. The glycemic benefits are largely due to the caloric restriction and weight loss achieved. While surgery is more effective at producing and sustaining this weight loss than lifestyle changes alone, the underlying mechanism is energy balance, not a unique surgical hormone effect. Patients should understand that achieving similar weight loss through other means could yield similar metabolic improvements, though sustaining that loss is the primary challenge.

Consuming a gluten-free meal results in a significantly lower postprandial thermogenic response (calorie burn) compared to iso-caloric whole food or ultra-processed meals in young women.

If you are eating gluten-free products for weight loss, be aware that they may not offer a metabolic advantage. This study found that gluten-free meals resulted in lower calorie burning (thermogenesis) after eating compared to both whole food and ultra-processed meals, provided the calories and macronutrients were the same. Focus on whole, unprocessed foods rather than just the absence of gluten for optimal metabolic response.

Lifestyle interventions for type 2 diabetes prevention in women with a history of gestational diabetes are only effective in reducing T2DM risk if participants have a baseline mean BMI of 30 kg/m2 or higher.

If you have a history of gestational diabetes and a BMI of 30 or higher, lifestyle interventions (diet and exercise) are highly effective at preventing type 2 diabetes. If your BMI is lower, these interventions may not significantly reduce your T2DM risk, though they may still help with weight management.

Fixed-amount food vouchers are less effective per person in larger households, requiring higher dollar values to achieve the same dietary improvement as in smaller households.

If you manage a food assistance program, do not give a flat $20 voucher to a family of 8 and expect the same per-person dietary benefit as for a single person. The subsidy is diluted. To help larger families achieve similar health outcomes, you must either increase the total dollar amount or provide additional non-financial support to help them navigate purchasing for more people.

Bariatric surgery is more cost-effective in the long term than non-surgical management of obesity because it reverses or improves obesity-related diseases like type 2 diabetes.

If you meet the criteria for bariatric surgery (BMI ≥40 or ≥35 with diabetes), discuss it with your doctor. While it has higher upfront costs and risks, it is often more cost-effective in the long run because it can reverse type 2 diabetes and other obesity-related diseases. Ensure you are medically and psychologically ready before proceeding.

Metabolic bariatric surgery (specifically malabsorptive procedures like Roux-en-Y gastric bypass) offers higher remission rates for Type 2 Diabetes than restrictive procedures (like sleeve gastrectomy), particularly in patients with severe obesity (BMI ≥ 35).

If you have severe obesity (BMI 35+) and Type 2 Diabetes, metabolic surgery (specifically bypass) is the most effective intervention for remission, offering double the success rate of sleeve gastrectomy. While invasive, it provides superior long-term glycemic control and lower relapse rates compared to other surgical options.

Physical activity levels are significantly lower in obese patients with Type 2 Diabetes compared to non-obese patients, and this difference persists even when total energy intake is similar between groups.

Obese diabetic patients tend to be significantly less physically active than non-obese patients. Since calorie intake may not differ, increasing physical activity is a critical component of weight management.

Sustained moderate-intensity exercise (approx. 2000 kcal/week) prevents weight gain in young overweight women but produces significant fat loss in young overweight men, independent of dietary changes.

If you are a young overweight man, doing ~45 minutes of moderate exercise (where you can talk but not sing) 5 days a week will likely help you lose fat, even if you don't change your diet. If you are a young overweight woman, the same routine will likely stop you from gaining weight, which is a significant health benefit compared to doing nothing, even if the scale doesn't drop.

Waist circumference (WC) is a critical, 'vital' parameter for assessing cardiovascular risk in obesity, providing prognostic information that BMI alone fails to capture, particularly regarding visceral adipose tissue (VAT).

Ask your doctor to measure your waist circumference at every visit. It is a key indicator of heart disease risk that weight alone cannot show, especially if you have a 'normal' weight but carry fat around your midsection.

SGLT2 inhibitors reduce body weight and blood pressure, contributing to their overall benefit in CRM syndrome.

SGLT2 inhibitors typically lead to a modest weight loss of 1.5-3 kg over 1-2 years, which is a beneficial side effect for managing metabolic syndrome.

Skeletal muscle loss during pharmacologically induced weight loss is clinically significant because excessive SMM loss reduces resting energy expenditure (REE), making weight maintenance more difficult.

To maintain weight loss, preserving muscle is critical because muscle burns calories at rest. If you lose too much muscle, your metabolism slows down, making it harder to stay lean. Ensure your weight loss plan includes adequate protein and resistance training to protect muscle mass.

Bariatric surgery is indicated for patients with BMI >= 40 kg/m2 or >= 35 kg/m2 with comorbidities, and offers benefits beyond weight loss including glycemic control and improved life expectancy.

If your BMI is 40+ (or 35+ with health issues), surgery is a valid option. It's not just weight loss; it can fix diabetes and other issues. Choose an experienced surgeon and commit to long-term follow-up.

Dietary capsinoids (9 mg/day) increase resting energy expenditure and brown adipose tissue density in healthy and overweight middle-aged adults.

Take 9 mg of capsinoids daily. This simple supplement has been shown in human trials to increase your resting energy expenditure and increase the amount of active brown fat, even in overweight individuals. It is a low-effort way to slightly boost your metabolic rate.

Caffeine (375 mg capsule or equivalent from coffee/tea) increases energy expenditure and brown adipose tissue activity in physically active humans.

Consume 375 mg of caffeine (or equivalent from coffee/tea) 30 minutes before activity. This has been shown to increase energy expenditure and activate brown fat, particularly in physically active men. It is a practical way to leverage a common substance for metabolic benefit.

Dietary weight loss interventions result in a consistent percentage of lean mass loss (approximately 29-30%) regardless of the total magnitude of weight lost, provided the loss exceeds 5% of baseline body weight.

If you lose weight through diet, expect to lose about 30% of that weight as lean mass, regardless of whether you lose 5% or 15% of your body weight. This is a consistent biological response to caloric restriction, not a failure of your diet. To mitigate this, incorporate resistance training, as the paper notes this is a benchmark for 'dietary modifications' without medication.

Total daily energy expenditure (TDEE) declines significantly with age in both males and females, primarily driven by reductions in fat-free mass and increases in fat mass, with the most substantial drop occurring during the transition from middle age to older adulthood.

Your daily calorie needs drop as you age, especially after 55. This isn't just 'hormones'; it's largely because you lose muscle (fat-free mass) and gain fat. To maintain your weight, you must adjust your caloric intake or increase activity to match this lower expenditure. Focus on preserving muscle mass through resistance training to keep your metabolic rate higher.

Females have a higher percentage of body fat and fat mass, and lower fat-free mass compared to males across all age groups, but the trajectory of body composition change with age is similar between sexes.

Women naturally carry more fat and less muscle than men, which lowers their baseline calorie needs. However, as you age, your body composition changes (losing muscle, gaining fat) in a pattern very similar to men. Focus on strength training to preserve muscle mass; this is the most effective way to counteract the age-related drop in energy expenditure for both sexes.

Orlistat is an affordable option with lower effectiveness, making it a practical alternative in resource-limited settings.

Orlistat (120 mg three times daily) is an affordable option for weight loss, but it has lower effectiveness compared to newer drugs like Semaglutide, making it a practical choice primarily in resource-limited settings.

Bariatric surgery results in greater weight loss and improvement in cardiac troponins compared to intensive lifestyle intervention alone in patients with severe obesity.

For severe obesity, bariatric surgery is more effective than lifestyle changes alone for weight loss and improving heart health markers like cardiac troponins. It is considered when other treatments fail.